#astrazeneca's ADC #enhertu is now approved in #us for HR-positive, HER2-low or ultra low #breastcancer https://www.ipharmacenter.com/post/astrazeneca-s-adc-enhertu-is-now-approved-in-us-for-hr-postive-her2-low-or-ultralow-breast-cancer #pharma #pharmaceutical #science #news #media #medicine #usa #usnews #healthcare #medcomms #medicalaffairs #medical #trump #presidenttrump